News

IOBS are a relatively new classification of pathogen detection equipment that use advanced fiber optic-based technology to detect a wide variety of human and animal pathogens. These devices

Abbott has posted a net income of $1bn for the first quarter 2010, or $0.64 per diluted share, a decrease of 30.3%, compared to $1.43bn, or $0.92 per

The Advia Chemistry Ecstasy assay allows the choice of two cut-off values (300ng/ml and 500ng/ml), complying with both the latest Samhsa1 recommendations as well as EWDTS2 guidelines. The

Amgen has posted a net income of $1.16bn for the first quarter 2010, or $1.18 per diluted share, compared to $1.01bn, or $0.98 per diluted share, for the

Arzerra is indicated for the treatment of chronic lymphocytic leukaemia (CLL) in patients who are refractory to fludarabine and alemtuzumab. GSK claimed that Arzerra is a new monoclonal

Through this agreement, BioServe, a provider of CLIA-certified genetic testing services, will provide NGC Medical with a full complement of CLIA-certified personalized genomics services, including DNA extraction, QC

ASG-5ME is an ADC composed of a fully human antibody directed to AGS-5, a new cancer target discovered by Agnes. The antibody is attached to a potent, synthetic

As per the collaboration, which was signed on March 2008, the companies will leverage a number of Silence’s proprietary lipid delivery and targeting technologies to develop new delivery

The Genous Bio-engineered Cobalt Chromium Stent combines OrbusNeich’s patented endothelial progenitor cell (EPC) capture technology Genous with a L605 cobalt chromium bare metal stent based on the company’s